(Q35157613)

6 August 2017

1 reference

title

The role of vitamin E in atherosclerosis (English)

1 reference

6 August 2017

1 reference

3

Roland Stocker

1 reference

6 August 2017

1

Joanne M Upston

1 reference

6 August 2017

Leonard Kritharides

2

1 reference

6 August 2017

publication date

1 September 2003

1 reference

Progress in Lipid Research

6 August 2017

published in

1 reference

6 August 2017

volume

42

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

page(s)

405-422

1 reference

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

The role of oxidized lipoproteins in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Characterization of CLA-1, a Human Homologue of Rodent Scavenger Receptor BI, as a Receptor for High Density Lipoprotein and Apoptotic Thymocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Native and Modified Low Density Lipoproteins Increase the Functional Expression of the Macrophage Class B Scavenger Receptor, CD36

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Lipids and oxidised lipids in human atheroma and normal aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Human Atherosclerotic Plaque Contains Both Oxidized Lipids and Relatively Large Amounts of α-Tocopherol and Ascorbate

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Coexistence of oxidized lipids and alpha-tocopherol in all lipoprotein density fractions isolated from advanced human atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Oxidized lipid accumulates in the presence of alpha-tocopherol in atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Continuous monitoring of in vitro oxidation of human low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Mechanism of uptake of copper-oxidized low density lipoprotein in macrophages is dependent on its extent of oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Vitamin E oxidation in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Scavenger receptor-independent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Autoxidation of lipids and antioxidation by alpha-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Two distinct pathways of formation of 4-hydroxynonenal. Mechanisms of nonenzymatic transformation of the 9- and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Alpha-tocopherol mediated peroxidation in the copper (II) and met myoglobin induced oxidation of human low density lipoprotein: the influence of lipid hydroperoxides.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Role of alpha-tocopheroxyl radical in the initiation of lipid peroxidation in human low-density lipoprotein exposed to horse radish peroxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Minimizing tocopherol-mediated radical phase transfer in low-density lipoprotein oxidation with an amphiphilic unsymmetrical azo initiator

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Inverse deuterium kinetic isotope effect for peroxidation in human low-density lipoprotein (LDL): a simple test for tocopherol-mediated peroxidation of LDL lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Alpha-tocopherol as a reductant for Cu(II) in human lipoproteins. Triggering role in the initiation of lipoprotein oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Requirement for, Promotion, or Inhibition by α-Tocopherol of Radical-Induced Initiation of Plasma Lipoprotein Lipid Peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

α‐Tocopherol does not inhibit hypochlorite‐induced oxidation of apolipoprotein B‐100 of low‐density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Involvement of 15-lipoxygenase in early stages of atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Presence of hypochlorite-modified proteins in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

p-Hydroxyphenylacetaldehyde, the major product of L-tyrosine oxidation by the myeloperoxidase-H2O2-chloride system of phagocytes, covalently modifies epsilon-amino groups of protein lysine residues

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Myeloperoxidase produces nitrating oxidants in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Prevention of tocopherol-mediated peroxidation in ubiquinol-10-free human low density lipoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

3-Hydroxyanthranilic acid is an efficient, cell-derived co-antioxidant for alpha-tocopherol, inhibiting human low density lipoprotein and plasma lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

α-Tocopheryl hydroquinone is an efficient multifunctional inhibitor of radical-initiated oxidation of low density lipoprotein lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Vitamin E consumption and the risk of coronary disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Vitamin E consumption and the risk of coronary heart disease in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS).

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Efficacy of vitamin E compared with either simvastatin or atorvastatin in preventing the progression of atherosclerosis in homozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Vitamin E supplementation and cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Dietary l-arginine and α-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Dietary cosupplementation with vitamin E and coenzyme Q(10) inhibits atherosclerosis in apolipoprotein E gene knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

The effect of alpha tocopherol on experimental atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Potentiation of atherosclerotic lesions in rabbits by a high dietary level of vitamin E

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Effect of vitamin E on aortic lipid oxidation and intimal proliferation after arterial injury in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Alpha-tocopherol protects against diet induced atherosclerosis in New Zealand white rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Intimal lesions in arteries of vit. E deficient rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Relation of vascular oxidative stress, alpha-tocopherol, and hypercholesterolemia to early atherosclerosis in hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Effect of dietary catechin and vitamin E on aortic fatty streak accumulation in hypercholesterolemic hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Effect of vitamin E and probucol on dietary cholesterol-induced atherosclerosis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Comparison of the effects of alpha-tocopherol, ubiquinone-10 and probucol at therapeutic doses on atherosclerosis in WHHL rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Lipids of human atheroma: Isolation of hydroxyoctadecadienoic acids from advanced aortal lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Vitamin E levels in human atherosclerotic plaque: the influence of risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Depletion of alpha-tocopherol in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Gas chromatography-mass spectrometry analysis of vitamin E and its oxidation products

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Lipids and oxidised lipids in human atherosclerotic lesions at different stages of development

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Oxidants and antioxidants in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Identification and quantification of regioisomeric cholesteryl linoleate hydroperoxides in oxidized human low density lipoprotein and high density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Inhibition by a coantioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Anti-atherogenic effect of coenzyme Q10 in apolipoprotein E gene knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Vitamin E and vascular homeostasis: implications for atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Vitamin E and atherosclerosis: beyond prevention of LDL oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

The European perspective on vitamin E: current knowledge and future research

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Supplementation with vitamin E and/or zinc does not attenuate atherosclerosis in apolipoprotein E-deficient mice fed a high-fat, high-cholesterol diet

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Effect of vitamin E on the development of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F(2alpha)-VI levels and the extent of atherosclerosis in ApoE-deficient mice: modulation by vitamin E.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900024-9

7 January 2021

10.1016/S0163-7827(03)00024-9

Identifiers

DOI

1 reference

6 August 2017

1 reference